Latest Articles
About This Stock
More About This Stock
Read
Read
Bioniche: A Home Run Buying Opportunity In Biotech
Article By:
Sujan Lahiri
Thursday, September 18, 2014 9:38 AM EDT
There is a critical medical need for Bioniche's technology in a $1 billion market virtually free of real competition, which opens the door for massive revenue growth, while the sound financials limits downside risk. Overall, today's $0.20 share price appears to me as an excellent entry point...
Twitter Tumbles As Solar Stocks Soar
Article By:
John Nyaradi
Tuesday, December 31, 2013 2:04 PM EDT
TWTR was grounded on Monday, after falling a total of 19.02% over a two-day period. Meanwhile, the solar sector continued to recover from its early-December slump.
In this article: DDD, CSIQ, FSLR, IBB, RGSE, SOXX, SPWR, SSYS, GALE, BBH, FBT, IYW, SMH, TAN, VGT, XBI, XLK, ONVO, TWTR